Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A form of autoimmune hepatitis characterized by the features of classic autoimmune hepatitis (i. e. clinical presentation as acute or chronic cryptogenic hepatitis, interface hepatitis on histological examination, elevated serum aspartate aminotransferase and alanine aminotransferase levels, hypergammaglobulinemia/elevated immunoglobulin G, therapeutic response to corticosteroids) in the absence of serum autoantibodies. Clinical manifestations include fatigue, malaise, arthralgia, jaundice, at later stages also signs of advanced chronic liver disease, such as spider nevi, caput medusae, splenomegaly, ascites, and palmar erythema. Presence of concurrent autoimmune diseases is frequently observed.
Biomarker and diagnostic research for seronegative autoimmune hepatitis has been reported in the published literature.
No clinical trials have been registered for seronegative autoimmune hepatitis.
11 publications have been identified in PubMed for seronegative autoimmune hepatitis. Research spans Case Report / Case Series (45%), Epidemiology / Natural History (18%), and Other (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 45% |
Data assembled from 3 of 12 sources · Last updated Sep 18, 2026, 7:44 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
2 |
18% |
Other research | 1 | 9% |
Testing and diagnosis research | 1 | 9% |
Research summaries | 1 | 9% |
Laboratory research | 1 | 9% |
McLeod B (2026). [PMID: 41883708](https://pubmed.ncbi.nlm.nih.gov/41883708/). *ACG Case Rep J*. [Case Report / Case Series]
Colapietro F (2026). [PMID: 42068086](https://pubmed.ncbi.nlm.nih.gov/42068086/). *Liver Int*. [Diagnostic / Biomarker]
Marfo E (2026). [PMID: 41883710](https://pubmed.ncbi.nlm.nih.gov/41883710/). *ACG Case Rep J*. [Case Report / Case Series]
Sahbani F (2026). [PMID: 41834055](https://pubmed.ncbi.nlm.nih.gov/41834055/). *J Med Case Rep*. [Case Report / Case Series]
Karthikeyan A (2026). [PMID: 41210108](https://pubmed.ncbi.nlm.nih.gov/41210108/). *J Clin Exp Hepatol*. [Basic Science / Preclinical]
Delle Cave V (2026). [PMID: 41796745](https://pubmed.ncbi.nlm.nih.gov/41796745/). *Ann Hepatol*. [Epidemiology / Natural History]
Kloub M (2025). [PMID: 40109823](https://pubmed.ncbi.nlm.nih.gov/40109823/). *Cureus*. [Case Report / Case Series]
Khanna R (2025). [PMID: 41264209](https://pubmed.ncbi.nlm.nih.gov/41264209/). *Hepatol Int*. [Review / Meta-Analysis]
Jannone G (2025). [PMID: 40819988](https://pubmed.ncbi.nlm.nih.gov/40819988/). *Dig Liver Dis*. [Case Report / Case Series]
Schmutz M (2024). [PMID: 39328418](https://pubmed.ncbi.nlm.nih.gov/39328418/). *Front Immunol*. [Epidemiology / Natural History]